465 related articles for article (PubMed ID: 7515142)
1. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142
[TBL] [Abstract][Full Text] [Related]
2. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
5. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
6. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
8. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
J Med Virol; 1994 Sep; 44(1):92-5. PubMed ID: 7528262
[TBL] [Abstract][Full Text] [Related]
9. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan.
Tsai JF; Chang WY; Jeng JE; Ho MS; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Tsai JH
J Med Virol; 1993 Dec; 41(4):296-300. PubMed ID: 7508973
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
12. Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia.
Bile K; Aden C; Norder H; Magnius L; Lindberg G; Nilsson L
Scand J Infect Dis; 1993; 25(5):559-64. PubMed ID: 7506842
[TBL] [Abstract][Full Text] [Related]
13. The role of hepatitis C virus in chronic hepatitis B virus infection.
Chuang WL; Chang WY; Lu SN; Lin ZY; Chen SC; Hsieh MY; Wang LY; You SL; Chen CJ
Gastroenterol Jpn; 1993 May; 28 Suppl 5():23-7. PubMed ID: 7689504
[TBL] [Abstract][Full Text] [Related]
14. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
Di Bisceglie AM; Simpson LH; Lotze MT; Hoofnagle JH
J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758
[TBL] [Abstract][Full Text] [Related]
15. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study.
Chuang WL; Chang WY; Lu SN; Su WP; Lin ZY; Chen SC; Hsieh MY; Wang LY; You SL; Chen CJ
Cancer; 1992 Apr; 69(8):2052-4. PubMed ID: 1311978
[TBL] [Abstract][Full Text] [Related]
16. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.
Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R
J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic assessment of interactions of hepatitis-C virus with seromarkers of hepatitis-B and -D viruses, cirrhosis and tobacco smoking in hepatocellular carcinoma.
Tzonou A; Trichopoulos D; Kaklamani E; Zavitsanos X; Koumantaki Y; Hsieh CC
Int J Cancer; 1991 Sep; 49(3):377-80. PubMed ID: 1655659
[TBL] [Abstract][Full Text] [Related]
18. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
19. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
20. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses.
Kato Y; Nakata K; Omagari K; Furukawa R; Kusumoto Y; Mori I; Tajima H; Tanioka H; Yano M; Nagataki S
Cancer; 1994 Oct; 74(8):2234-8. PubMed ID: 7922974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
